Profile
Raul Ziliotto worked as a Director in Drug Development at AGC Biologics SpA and Nerviano Medical Sciences SRL.
He also worked as a Director in Biological Products Development at Pharmacia Upjohn and Pharmacia Italia Spa.
Mr. Ziliotto completed his undergraduate degree at the University of Milan.
Former positions of Raul Ziliotto
| Companies | Position | End |
|---|---|---|
| Pharmacia Italia Spa | Corporate Officer/Principal | 2004-12-31 |
Nerviano Medical Sciences SRL
 Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Corporate Officer/Principal | - |
| Pharmacia Upjohn | Corporate Officer/Principal | - |
| MOLMED S.P.A. | Corporate Officer/Principal | - |
Training of Raul Ziliotto
| University of Milan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AGC Biologics SpA
 AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
| Pharmacia Italia Spa | |
| Pharmacia Upjohn | |
Nerviano Medical Sciences SRL
Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Health Technology |
- Stock Market
- Insiders
- Raul Ziliotto
